Clinical trials
Completed Phase 2 Memory Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 3 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Avraham Pharmaceuticals Ltd | 2 |
| University of California, Los Angeles | 2 |
| AbbVie | 1 |
| Alzheimer's Disease Cooperative Study (ADCS) | 1 |
| Celgene Corporation | 1 |
| Eli Lilly and Company | 1 |
| Emory University | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Intermountain Health Care, Inc. | 1 |
| Johns Hopkins University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memory Disorders | 24 |
| Alzheimer Disease | 12 |
| Cognitive Dysfunction | 12 |
| Dementia | 10 |
| Brain Diseases | 2 |
| Mental Disorders | 2 |
| Nervous System Diseases | 2 |
| Neurodegenerative Diseases | 2 |
| Tauopathies | 2 |
| Anxiety Disorders | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.